4/A

PRIMARY DOCUMENT

Company: ENANTA PHARMACEUTICALS INC
Filed: November 22, 2016
Period of Report: November 20, 2014
Accession Number: 0001177648-16-000022

View Document ↗ View on SEC.gov ↗